Adams Respiratory Therapeutics, Inc. 4
4 · Adams Respiratory Therapeutics, Inc. · Filed May 29, 2007
Insider Transaction Report
Form 4
Casale Robert Daniel
EVP, Chief Mktg & Devel. Off.
Transactions
- Sale
Common Stock
2007-05-25$39.99/sh−3,000$119,970→ 0 total - Exercise/Conversion
Common Stock
2007-05-25$1.42/sh+3,000$4,260→ 3,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2007-05-25−3,000→ 54,960 totalExercise: $1.42Exp: 2014-02-27→ Common Stock (3,000 underlying)
Footnotes (2)
- [F1]The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 13, 2007.
- [F2]The option vests in prorata monthly installments over five years, beginning on April 1, 2004.